Frequently Asked Questions
The market is segmented based on Global Medicinal Chemistry for Drug Discovery Market, By Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation), Design (Fragment-Based Variation, Structure-Based Drug Design, Diversity Oriented Synthesis, Chemogenomics, Natural Products, Others), Drug Type (Small Molecules, Biologics), Therapeutic Area (Oncology, Neurology, Infectious and Immune System Diseases, Cardiovascular Diseases, Digestive System Diseases, Others), End User (Contract Research Organization, Pharmaceuticals and Biotechnology Companies, Academic and Research Institutes, Others) – Industry Trends and Forecast to 2030.
.
The Global Medicinal Chemistry For Drug Discovery Market size was valued at USD 5379.22 USD Million in 2022.
The Global Medicinal Chemistry For Drug Discovery Market is projected to grow at a CAGR of 13.6% during the forecast period of 2023 to 2030.
The major players operating in the market include Eurofins Scientific, Covance , WuXi AppTec, Thermo Fisher Scientific, Evotec SE, Piramal Pharma Solutions, Pfizer, Certara, Sygnature Discovery Limited, Malvern Panalytical Ltd, Jubilant Biosys , Taros Chemicals GmbH & Co. KG, GenScript Biotech Corporation, Nereid Therapeutics , BioBlocks, Charnwood Molecular LTD, Domainex, Aurigene Pharmaceutical Services , Selvita, Nanosyn.
The market report covers data from the U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America.
